Univercells is dedicated to transforming the production of biotech drugs, which include vaccines and therapies derived from living organisms. The company focuses on streamlining and innovating the drug development process to make it faster, cheaper, and simpler, thereby increasing accessibility to life-changing treatments. Their approach involves the integration of advanced technologies and bioprocess know-how, which allows for significant reductions in both drug development timelines and costs. Univercells has developed a comprehensive suite of platforms that encompass the entire manufacturing process, ensuring compliance and efficiency while delivering ready-to-use drug solutions.

Among their key technological advancements is a bioinformatics platform that optimizes RNA sequence design, enabling the creation of highly functional RNA for various applications. They also utilize proprietary methods for translating RNA sequences into DNA templates, which enhances the speed and safety of production by eliminating risks associated with traditional methods. Their mRNA production process is designed to be construct-agnostic, scalable, and efficient, allowing for high yields and consistent quality. Additionally, Univercells is innovating in drug delivery systems, developing novel formulations to improve the effectiveness of mRNA vaccines. Through these technologies, Univercells aims to empower the pharmaceutical and biotech industries to produce life-saving products more effectively and affordably.

Belgium

For humanity to thrive, we need transformative thinking in how vaccines and therapeutics are designed and produced. At Univercells, we believe in the power of small adaptations to drive big change. We embrace the spirit of evolution in everything we do. 

We are biotech innovators. 
We are scientists and entrepreneurs creating transformative platforms for the pharmaceutical and biotech industry, through technology, bioprocess know-how and entrepreneurial spirit.

UNIVERCELLS

Company Details